Outcome of the Board Meeting held on Friday, 29th May 2026
and take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and Financial Year ended March 31, 2026 along Auditor''s Report thereon.
Update on Scheme of Arrangement involving Brooks Steriscience Limited ("BSL"), a Joint Venture / Associate of the Company.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 15.70 | 24.32 | 21.75 | 17.72 | 17.93 | 20.79 | 20.52 | 23.32 | 25.51 | 23.45 | 16.57 | 20.21 |
| YOY Revenue Growth % | -8.3% | 34.48% | 42.1% | 40.49% | 14.2% | -14.49% | -5.66% | 31.57% | 42.26% | 12.79% | -19.25% | -13.33% |
| Other Income | 0.05 | 0.09 | 0.16 | 0.65 | 0.07 | 0.20 | 0.03 | 0.62 | 0.22 | 0.39 | 0.13 | 0.44 |
| Total Income | 15.76 | 24.41 | 21.90 | 18.38 | 18.00 | 20.99 | 20.54 | 23.94 | 25.73 | 23.84 | 16.69 | 20.65 |
| Total Expenses + | 16.29 | 23.23 | 21.30 | 18.07 | 18.21 | 20.03 | 19.61 | 22.43 | 23.08 | 21.60 | 16.39 | 20.03 |
| Cost of Materials Consumed | 10.67 | 12.23 | 12.09 | 9.74 | 9.80 | 11.40 | 12.17 | 13.68 | 13.62 | 10.42 | 9.08 | 11.81 |
| Employee Benefit Expense | 2.77 | 2.65 | 2.84 | 2.28 | 3.07 | 3.21 | 3.29 | 3.38 | 3.67 | 3.93 | 3.72 | 3.85 |
| Other Expenses | 1.92 | 2.49 | 2.35 | 2.35 | 2.27 | 2.87 | 2.89 | 2.58 | 2.82 | 3.29 | 3.12 | 3.26 |
| Operating Profit | -0.59 | 1.09 | 0.45 | -0.35 | -0.28 | 0.76 | 0.91 | 0.89 | 2.43 | 1.85 | 0.18 | 0.18 |
| OPM % | -3.7% | 4.5% | 2.1% | -2% | -1.6% | 3.6% | 4.4% | 3.8% | 9.5% | 7.9% | 1.1% | 0.9% |
| Profit Before Tax + | -0.53 | 1.18 | 0.60 | 0.30 | -0.21 | 0.96 | 0.94 | 1.51 | 2.65 | 2.24 | 0.30 | 0.61 |
| Tax Expense | 3.94 | 2.82 | 4.48 | 9.91 | 2.20 | 4.92 | 3.07 | 2.97 | -6.93 | -5.74 | -5.20 | -0.91 |
| Tax % | - | 238.7% | 742.7% | 3266.4% | - | 514.7% | 327.7% | 196.4% | -261.6% | -256.5% | -1716% | -147.9% |
| Profit After Tax | -4.47 | -1.64 | -3.88 | -9.61 | -2.41 | -3.96 | -2.13 | -1.46 | 9.58 | 7.98 | 5.50 | 1.52 |
| EPS (Basic) | -1.75 | -0.64 | -1.51 | -3.77 | -0.94 | -1.51 | -0.82 | -0.54 | 3.25 | 2.71 | 1.87 | 0.52 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 85.74 | 82.56 | 79.49 | 63.20 | 91.08 | 77.25 |
| YOY Revenue Growth % | 3.85% | 3.86% | 25.76% | -30.6% | 17.9% | - |
| Other Income | 1.17 | 0.88 | 0.96 | 0.20 | 0.91 | 0.74 |
| Total Income | 86.91 | 83.44 | 80.44 | 63.41 | 91.99 | 77.98 |
| Total Expenses + | 81.10 | 80.25 | 78.89 | 98.83 | 115.88 | 86.97 |
| Cost of Materials Consumed | 49.61 | 47.04 | 44.72 | 41.55 | 62.93 | 46.67 |
| Employee Benefit Expense | 15.16 | 12.96 | 10.54 | 17.34 | 19.15 | 14.37 |
| Other Expenses | 12.49 | 10.58 | 9.11 | 21.68 | 23.50 | 14.78 |
| Operating Profit | 4.63 | 2.31 | 0.60 | -35.63 | -24.81 | -9.72 |
| OPM % | 5.4% | 2.8% | 0.8% | -56.4% | -27.2% | -12.6% |
| Profit Before Exceptional | 5.81 | 3.19 | 1.55 | -35.42 | -23.90 | -8.99 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | -0.36 | 0.00 | 0.00 |
| Profit Before Tax + | 5.81 | 3.19 | 1.55 | -35.78 | -23.90 | -8.99 |
| Tax Expense | -18.78 | 13.16 | 21.15 | -4.01 | -4.59 | 10.39 |
| Tax % | -323.5% | 412.2% | 1360.3% | - | - | - |
| Profit After Tax | 24.58 | -9.97 | -19.59 | -31.77 | -19.31 | -19.38 |
| EPS (Basic) | 8.35 | -3.72 | -7.67 | -12.57 | -7.82 | 6.31 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 110.76 | 89.82 | 59.40 | 81.99 | 134.73 | 111.76 |
| Property, Plant & Equipment | 13.41 | 12.51 | 13.07 | 14.02 | 108.32 | 107.03 |
| Capital Work in Progress | 1.19 | 1.46 | 0.00 | 0.00 | 15.11 | 0.68 |
| Non-Current Investments | 92.34 | 73.55 | 42.91 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 0.01 | 0.60 | 0.99 | 1.69 | 0.67 |
| Current Assets + | 37.42 | 33.88 | 31.05 | 27.61 | 61.18 | 47.80 |
| Inventories | 11.02 | 9.20 | 9.61 | 11.30 | 27.52 | 23.60 |
| Trade Receivables | 16.11 | 19.99 | 16.32 | 12.75 | 17.66 | 13.70 |
| Cash and Cash Equivalents | 6.59 | 0.04 | 0.13 | 0.02 | 2.61 | 0.88 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 122.66 | 98.10 | 65.59 | 73.95 | 134.32 | 79.15 |
| Equity Share Capital | 29.46 | 29.46 | 26.25 | 24.70 | 24.70 | 24.70 |
| Other Equity | 93.20 | 68.65 | 39.34 | 49.25 | 38.35 | 54.45 |
| Non-Current Liabilities | 3.70 | 2.75 | 1.81 | 2.62 | 12.71 | 19.21 |
| Current Liabilities | 21.81 | 22.84 | 23.05 | 33.02 | 48.88 | 63.71 |
| Total Liabilities | 25.52 | 25.59 | 24.86 | 35.64 | 61.59 | 82.93 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 9.29 | 2.52 | -9.68 | -14.49 | -37.44 | 4.46 |
| Cash from Investing Activities | -2.92 | -45.97 | 0.18 | 0.49 | -24.91 | -5.13 |
| Cash from Financing Activities | 0.17 | 43.36 | 9.60 | 11.41 | 64.07 | 1.16 |
| Net Increase/Decrease in Cash | 6.54 | -0.08 | 0.10 | -2.58 | 1.72 | 0.49 |